首页> 外文学位 >1. Evaluation of polycarbophil coated liposomes and membrane permeation of free and liposomal drugs, 2. In vitro-in vivo evaluation of nicardipine HCl sustained-release formulations
【24h】

1. Evaluation of polycarbophil coated liposomes and membrane permeation of free and liposomal drugs, 2. In vitro-in vivo evaluation of nicardipine HCl sustained-release formulations

机译:1.评估聚卡波非包衣的脂质体和游离药物和脂质体药物的膜渗透性,2.尼卡地平HCl缓释制剂的体外-体内评估

获取原文
获取原文并翻译 | 示例

摘要

An evaluation of polycarbophil coated liposomes and nicardipine HCl oral sustained-release formulations are detailed and explained. Polycarbophil coated liposomes were characterized for their drug release, loss of entrapped drug, and membrane permeation. Weights of liposomes during incubation with polycarbophil increased as a function of time. The three model drugs entrapped in liposomes were insulin, dyphylline, and hydrocortisone. Rates of drug release from liposomes were not significantly controlled by the polycarbophil coating. Loss of the entrapped insulin (high MW) was reduced when 1-1.5% polycarbophil solution was applied as coating over the liposomes. In contrast, loss of the entrapped dyphylline and hydrocortisone (low MW) was not affected by polycarbophil coating. Low amounts of insulin, dyphylline, or hydrocortisone were transported across an ethylenevinylacetate membrane in membrane permeation studies. The amounts of drug, entrapped in liposomes, penetrated through the membrane were too low to detect. Polycarbophil coated liposomes may be a promising drug carrier for topical application.;Nicardipine HCl sustained-release products were formulated and evaluated in vitro and in vivo. Appropriate methods and dissolution media for in vitro dissolution testing were investigated and selected. Both enzyme-free simulated gastric and intestinal fluids were required for dissolution testing of sustained-release drug products. Release rates of nicardipine HCl using USP basket or paddle at 50 RPM were comparable to Bio-Dis$spcircler$ at 5 or 10 DPM. Bio-Dis$spcircler$ was the most convenient method, and was therefore selected for product evaluation.;Nicardipine HCl sustained-release products consisted of 75% sustained-release beads and 25% immediate-release powder. Rates of drug release from the beads were controlled by percentages of ethylcellulose used in a spray layering process, but not significantly affected by incorporation of PVP at 10-15%. Rates of drug release were retarded by overcoating with ethylcellulose. Diluent incorporated in immediate-release powder had an influence on flow properties of powder.;A newly developed nicardipine HCl product was tested for bioequivalence with Cardene$spcircler$ SR. Statistical two one-sided t-test indicated that the two products could not be concluded as being bioequivalent. In vitro/in vivo correlation of percentages of drug release was found after the in vitro time scale was corrected.
机译:详细描述了聚卡波非包衣的脂质体和尼卡地平HCl口服缓释制剂的评价。聚卡波非包衣的脂质体的特征在于其药物释放,截留的药物损失和膜渗透。与聚卡波非一起孵育期间,脂质体的重量随时间增加。包裹在脂质体中的三种模型药物是胰岛素,茶碱和氢化可的松。聚卡波非涂层没有明显控制药物从脂质体释放的速率。当将1-1.5%的聚卡波非溶液涂在脂质体上时,减少了包裹的胰岛素(高分子量)的损失。相反,聚卡波非包衣层不影响包埋的茶碱和氢化可的松(低分子量)的损失。在膜渗透研究中,少量的胰岛素,茶碱或氢化可的松通过乙烯乙酸乙烯酯膜转运。包裹在脂质体中的药物透过膜的量太低而无法检测到。聚卡波非包衣的脂质体可能是局部应用的有希望的药物载体。尼卡地平HCl缓释产品的配制和体外和体内评价。研究并选择了用于体外溶出度测试的合适方法和溶出介质。持续释放药物产品的溶出度测试均需要无酶模拟胃液和肠液。使用USP篮或桨在50 RPM下释放的尼卡地平HCl的释放速率与5 DPM或10 DPM下的Bio-Disspcircler $相当。 Bio-Discircspler $是最方便的方法,因此被选作产品评估。尼卡地平HCl缓释产品由75%的缓释珠和25%的速释粉组成。药物从微珠中释放的速率受喷雾分层过程中使用的乙基纤维素的百分比控制,但不受PVP掺入10-15%的影响较大。通过用乙基纤维素进行包衣来延迟药物释放的速率。速释粉中掺入的稀释剂对粉的流动性有影响。;使用Cardene®spcircler $ SR测试了新开发的盐酸尼卡地平产品的生物等效性。统计的两个单侧t检验表明,不能得出两种产品具有生物等效性的结论。校正体外时间尺度后,发现了药物释放百分比的体外/体内相关性。

著录项

  • 作者

    Sorasuchart, Waranush.;

  • 作者单位

    Oregon State University.;

  • 授予单位 Oregon State University.;
  • 学科 Pharmaceutical sciences.
  • 学位 Ph.D.
  • 年度 1998
  • 页码 157 p.
  • 总页数 157
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-17 11:48:49

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号